Format

Send to

Choose Destination
J Thorac Cardiovasc Surg. 2018 Feb;155(2):632-638. doi: 10.1016/j.jtcvs.2017.09.092. Epub 2017 Sep 28.

Pattern and predictors of dual antiplatelet use after coronary artery bypass graft surgery.

Author information

1
Section of Cardiac Surgery, Yale University School of Medicine, New Haven, Conn.
2
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Conn.
3
Section of Cardiac Surgery, Yale University School of Medicine, New Haven, Conn. Electronic address: arnar.geirsson@yale.edu.

Abstract

BACKGROUND:

Resumption of dual antiplatelet therapy after coronary artery bypass grafting in patients presenting with acute coronary syndrome is recommended, but the current practice pattern in the United States remains unknown. We aimed to investigate the current pattern of dual antiplatelet therapy use after coronary artery bypass grafting at the Yale-New Haven Hospital.

METHODS:

We conducted a single-center retrospective review of patients who presented with acute coronary syndrome and underwent coronary artery bypass grafting between 2014 and 2016. The primary outcome was hospital discharge with dual antiplatelet therapy. Mixed-effect multivariate logistic regression was used to evaluate predictors of dual antiplatelet therapy use or nonuse, accounting for surgeon-specific preference. The discriminatory ability of the model was evaluated with receiver operating characteristics analysis.

RESULTS:

Of 572 patients included, only 29% were discharged with dual antiplatelet therapy. In the mixed-effect multivariate model isolating surgeon preferences, increase in age (odds ratio, 0.95; 95% confidence interval, 0.92-0.98; P < .001) and discharge with anticoagulants (odds ratio, 0.20; 95% confidence interval, 0.07-0.55; P = .002) were associated with lower odds of dual antiplatelet therapy use. Off-pump coronary artery bypass grafting compared with on-pump coronary artery bypass grafting was associated with increased odds of dual antiplatelet therapy use (odds ratio, 31.5; 95% confidence interval, 12.8-77.2; P < .001). C-index of the prediction model was 0.74.

CONCLUSIONS:

The overall rate of dual antiplatelet therapy use in patients with acute coronary syndrome who underwent coronary artery bypass grafting was low and variable among surgeons. The use or nonuse was guided by previously established risk factors of recurrent ischemia and bleeding, along with surgeon preference.

KEYWORDS:

coronary artery bypass grafting; dual antiplatelet therapy; practice pattern

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center